Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Multimodal noninvasive and invasive imaging of extracranial venous abnormalities indicative of CCSVI: results of the PREMiSe pilot study.
Protein Kinase C-theta Inhibitors: A Novel Therapy for Inflammatory Disorders.
How does magnetization transfer influence mcDESPOT results?
Endovascular diagnosis and management of chronic cerebrospinal venous insufficiency: retrospective analysis of 30-day morbidity and mortality in 95 consecutive patients.
Cladribine in multiple sclerosis: pitfalls in a new treatment landscape.
Corneal Sensitivity and Tear Function in Neurodegenerative Diseases.
A new role for an old drug: Ambroxol triggers lysosomal exocytosis via pH-dependent Ca(2+) release from acidic Ca(2+) stores.
A Multiple Sclerosis-Associated Variant of CBLB Links Genetic Risk with Type I IFN Function.
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance.
Nigella sativa amliorates inflammation and demyelination in the experimental autoimmune encephalomyelitis-induced Wistar rats.
Multiple sclerosis databases: present and future.
Predictive value of MRI parameters in severity and recovery of first-episode myelitis in aquaporin-4 antibody disease.
Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data.
The squares test as a measure of hand function in multiple sclerosis.
Incidence and distribution of extravascular compression of extracranial venous pathway in patients with chronic cerebrospinal venous insufficiency and multiple sclerosis.
Connexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis optica.
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.
Psychiatric co-morbidity in multiple sclerosis: The risk of depression and anxiety before and after MS diagnosis.
Integrin-based therapeutics: biological basis, clinical use and new drugs.
Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis.
Utility of the rio score and modified rio score in korean patients with multiple sclerosis.
Relationship between contrast sensitivity test and disease severity in multiple sclerosis patients.
Demyelination and Neurodegeneration in Multiple Sclerosis: The Role of Hypoxia.
Central and peripheral demyelination.
Oral BG-12 in multiple sclerosis.

Pages